| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/09/2009 | US7544664 Sequences facilitating penetration of a substance of interest |
| 06/09/2009 | US7544660 Factor VIII polypeptide having factor VIII:C activity |
| 06/09/2009 | US7544658 Heat resistant vacuole transport protein for use as nanoactuator of micromachine or nanomachine |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544638 Device for chemical and biochemical reactions using photo-generated reagents |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544512 Transforming and fermenting gene products from cells comprising nucleotide sequences coding glucagon like polypeptides for use in stimulation and secretion of insulin; diabetes treatment; bioreactors |
| 06/09/2009 | US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus |
| 06/09/2009 | US7544509 Method for preparing stem cell preparations |
| 06/09/2009 | US7544499 For treating an animal suffering from an excess of CHASEGP substrate produced from glial scar resulting from spinal cord injury or surgery; herniated disk; genetic engineering |
| 06/09/2009 | US7544493 Method for the purification of an N-terminal fragment of hepatocyte growth factor |
| 06/09/2009 | US7544492 Polynucleotide sequences coding human weight regulatory protein; therapy and diagnostic tool for eating disorders, cachexia; gene therapy; modulators of body weight |
| 06/09/2009 | US7544491 TANGO 240 nucleic acids and uses thereof |
| 06/09/2009 | US7544490 Nucleic acid sequences encoding secretion-associated proteins; cells genetically manipulated to have an altered capacity to produce expressed proteins |
| 06/09/2009 | US7544489 Nucleic acid sequences encoding secretion-associated proteins; cells genetically manipulated to have an altered capacity to produce expressed proteins |
| 06/09/2009 | US7544488 Secretion, transcription and sporulation genes in Bacillus clausii |
| 06/09/2009 | US7544487 Fusion proteins containing recombinant cytotoxic RNAses |
| 06/09/2009 | US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders |
| 06/09/2009 | US7544485 Baldness related gene and the polypeptide encoded thereby, and uses |
| 06/09/2009 | US7544483 Method for the production of protamine |
| 06/09/2009 | US7544481 Nucleic acids encoding CD40 binding protein |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544477 Circularly permutated, interaction-activated proteins |
| 06/09/2009 | US7544468 Generating marker for genetic analysis; obtain cells, extract nucleotide sequences, incubate with solid support, recover genomic marker |
| 06/09/2009 | US7544467 Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV) |
| 06/09/2009 | US7544361 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration |
| 06/09/2009 | US7544358 Bacterial sepsis, hemorrhagic shock, toxic inhalation, and bleomycin and other drug-induced lung injury; fibronectin and tenascin receptor antagonist; cancer |
| 06/09/2009 | CA2493409C Functional screening method |
| 06/09/2009 | CA2402171C Reaction system for thermal cycling |
| 06/09/2009 | CA2317443C Agent for treating allergic or hypersensitivity condition |
| 06/09/2009 | CA2304367C An improved yeast interaction trap assay |
| 06/09/2009 | CA2269083C Novel fgf homologs |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/09/2009 | CA2205118C Dna molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules |
| 06/09/2009 | CA2199408C Herpes simplex virus glycoprotein d variants |
| 06/09/2009 | CA2155017C Vpr function and activity |
| 06/07/2009 | CA2645702A1 Soybean cultivar hfpr-5 |
| 06/04/2009 | WO2009070805A2 Mir-124 regulated genes and pathways as targets for therapeutic intervention |
| 06/04/2009 | WO2009070636A2 Engineered cells, imaging reporter gene/probe systems, and methods of imaging |
| 06/04/2009 | WO2009070609A2 Therapeutic targeting of il-6 using sirna in neutral liposomes |
| 06/04/2009 | WO2009070558A1 Method for isolation of genomic dna, rna and proteins from a single sample |
| 06/04/2009 | WO2009070465A1 Selective purification of small rnas from mixtures |
| 06/04/2009 | WO2009070234A2 Complexation of fatty acid-conjugated molecules with albumin |
| 06/04/2009 | WO2009069986A2 Genetically-modified cell line for producing cloned miniature pigs for xenotransplantation and method for preparing the same. |
| 06/04/2009 | WO2009069979A1 An assay system for transforming growth factor-beta and smad activity and its application |
| 06/04/2009 | WO2009069935A2 Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| 06/04/2009 | WO2009069862A1 Production of soluble recombinant protein by pi value control of n-terminal |
| 06/04/2009 | WO2009069808A1 Epha4 polypeptide having novel activity and use thereof |
| 06/04/2009 | WO2009069800A1 Novel aminoglycoside antibiotic, method for producing the same, and pharmaceutical use of the same |
| 06/04/2009 | WO2009069711A1 Carrier, method and reagent for obtaining small rna |
| 06/04/2009 | WO2009069704A1 Lactic acid bacterium having effect of lowering blood uric acid level |
| 06/04/2009 | WO2009069546A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 06/04/2009 | WO2009069538A1 Ethanol production process, and yeast for ethanol production |
| 06/04/2009 | WO2009069447A1 Adjuvant for influenza vaccine, and influenza vaccine |
| 06/04/2009 | WO2009069381A1 Transformant transfected with flavin adenine dinucleotide-binding glucose dehydrogenase gene and method for producing flavin adenine dinucleotide-binding glucose dehydrogenase using the same |
| 06/04/2009 | WO2009069355A1 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 06/04/2009 | WO2009069313A1 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron |
| 06/04/2009 | WO2009069302A1 Stat3 epitope peptides |
| 06/04/2009 | WO2009069123A2 Compositions comprising fibrous polypeptides and polysaccharides |
| 06/04/2009 | WO2009068870A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | WO2009068649A2 Antigen-binding constructs |
| 06/04/2009 | WO2009068645A1 Novel recombination sequences |
| 06/04/2009 | WO2009068588A2 Transgenic plants with increased stress tolerance and yield |
| 06/04/2009 | WO2009068564A1 Plants having enhanced yield-related traits and a method for making the same |
| 06/04/2009 | WO2009068481A1 Novel bank1 splice variant |
| 06/04/2009 | WO2009068456A1 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (tlx) |
| 06/04/2009 | WO2009068318A1 Mcp-i binding nucleic acids and use thereof |
| 06/04/2009 | WO2009068313A2 Brassica plant comprising a mutant indehiscent allele |
| 06/04/2009 | WO2009068308A2 New malonate decarboxylases for industrial applications |
| 06/04/2009 | WO2009068033A2 Lna antagonists targeting the androgen receptor |
| 06/04/2009 | WO2009067800A1 Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof |
| 06/04/2009 | WO2009067784A1 Nucleotide sequence encoding artemisinic aldehyde double bond reductase, artemisinic aldehyde double bond reductase and uses thereof |
| 06/04/2009 | WO2009067757A1 Methods of inducing pluripotency involving oct4 protein |
| 06/04/2009 | WO2009067756A1 Methods of inducing pluripotency involving sox2 protein |
| 06/04/2009 | WO2009067755A1 Therapeutic targets and medicaments involving p230/golgin-245 |
| 06/04/2009 | WO2009067751A1 Plants with modified starch metabolism |
| 06/04/2009 | WO2009067743A1 Enzymes for amplification and copying bisulphite modified nucleic acids |
| 06/04/2009 | WO2009051344A3 A vector for expressing antibody fragments and a method for producing recombinant phage that displays antibody fragments by using the vector |
| 06/04/2009 | WO2009050498A3 Chimeric constructs for eukaryotic membrane expression in prokaryotic cells |
| 06/04/2009 | WO2009047498A3 Mutant enzymes |
| 06/04/2009 | WO2009045469A3 Increasing erythropoietin using nucleic acids hybridizable to micro-rna and precursors thereof |
| 06/04/2009 | WO2009044154A3 Transcription factor decoys, compositions and methods |
| 06/04/2009 | WO2009044153A3 Inhibitors and uses |
| 06/04/2009 | WO2009040674A3 A public and immunogenic cd4+ t cell epitope of the hiv tat protein and its applications |
| 06/04/2009 | WO2009037439A3 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3 |
| 06/04/2009 | WO2009030863A3 Method for selecting oenological yeasts |
| 06/04/2009 | WO2009029739A3 Methods involving genes encoding nucleoside diphosphatase kinase (ndk) polypeptides and homologs thereof for modifying the plant's root architecture |
| 06/04/2009 | WO2009024986A3 Regulatory sequences derived from il-10 promoter and uses thereof in modulation of immune response |
| 06/04/2009 | WO2009022216A3 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 06/04/2009 | WO2008157827A3 Modified composition of plant extracellular lipids using acyltransferases and fatty acid omega-oxidases |
| 06/04/2009 | WO2008139262A3 Oligoribonucleotides and uses thereof |
| 06/04/2009 | WO2008129256A3 Hiv therapy |
| 06/04/2009 | WO2008121604A3 Compositions and methods for inhibiting expression of a gene from the ebola |
| 06/04/2009 | WO2008071385A3 Use of acetals for the isolation of nucleic acids |
| 06/04/2009 | WO2008022963A3 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
| 06/04/2009 | US20090144863 Expression Enhancing Intron Sequences |
| 06/04/2009 | US20090144860 Genes involved in asymmetric cell division |
| 06/04/2009 | US20090144859 GTP Binding Stress-Related Proteins and Methods of Use in Plants |
| 06/04/2009 | US20090144858 Genetic method |